Crescent Biopharma, Inc.CBIONASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-71.47M
↓ 59% below average
Average (9y)
$-44.98M
Historical baseline
Range
High:$-12.77M
Low:$-71.47M
CAGR
+21.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-71.47M | -93.7% |
| 2023 | $-36.90M | +21.0% |
| 2022 | $-46.69M | +26.4% |
| 2021 | $-63.43M | -24.3% |
| 2020 | $-51.03M | +5.7% |
| 2019 | $-54.12M | -12.1% |
| 2018 | $-48.27M | -45.0% |
| 2017 | $-33.28M | -4.6% |
| 2016 | $-31.81M | -149.1% |
| 2015 | $-12.77M | - |